LLS News Network

News and Information from The Leukemia & Lymphoma Society

LLS and Burlington Stores Celebrate 19 Years of Partnership in th...

Rye Brook, NY, September 24, 2020 – The Leukemia & Lymphoma Society (LLS), the world's largest nonprofit dedicated to fighting blood cancer, and the national off-price retailer, Burlington Stores, team up for the 19th consecutive year to raise critical funds for lifesaving research and cancer treatments. This year, funds raised in all Burlington store locations nationwide will not only support LLS’s...

The Leukemia & Lymphoma Society Launches First Clinical Trial Spe...

Rye Brook, NY (Wednesday, Sept. 9, 2020) - With studies showing between 30-60% of blood cancer patients at risk of death if infected with the COVID-19 virus compared to patients who are cancer-free, The Leukemia & Lymphoma Society (LLS) announced today it is launching the first clinical trial dedicated solely to this most vulnerable population.   This trial (LLS Protocol Number: BAML-16-001-COV1) will tes...

PRA Health Sciences Joins The Leukemia & Lymphoma Society on Glob...

September 3, 2020, Rye Brook, N.Y. and Raleigh, N.C. - The Leukemia & Lymphoma Society (LLS) and PRA Health Sciences (NASDAQ: PRAH) announced today a partnership to launch a first-of-its-kind global master clinical trial to develop new treatments for children with relapsed acute leukemia. The new LLS PedAL (Pediatric Acute Leukemia) master clinical trial will test, simultaneously, multiple targeted therapies f...

Blood Cancer Patients Need Support Now More Than Ever

(Rye Brook, NY, Sept. 1, 2020) — Having blood cancer is tough. Having blood cancer now is even tougher. Blood Cancer Awareness Month in September provides an opportunity to remind the public about the urgent need to support research to fight this deadly disease — a disease that is diagnosed every three minutes in the U.S. and has no current means of prevention. As the global leader in the fight against blood canc...

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: